Increase in both CD14-positive and CD15-positive myeloid-derived suppressor cell subpopulations in the blood of patients with glioma but predominance of CD15-positive myeloid-derived suppressor cells in glioma tissue.
about
Toward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ RegimenImmunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS SitesImmunosuppressive mechanisms in glioblastoma.CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients.Glioma: experimental models and reality.Myeloid-derived suppressor cells in gliomas.Pilot Study of Whole Blood MicroRNAs as Potential Tools for Diffuse Low-Grade Gliomas Detection.Immune microenvironment of gliomas.Myeloid-derived suppressor cells as effectors of immune suppression in cancer.Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotypeElevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function.GM-CSF signalling blockade and chemotherapeutic agents act in concert to inhibit the function of myeloid-derived suppressor cells in vitro.Immunotherapies for malignant glioma.Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion.Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer model.Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype.CD33+ HLA-DR- Myeloid-Derived Suppressor Cells Are Increased in Frequency in the Peripheral Blood of Type1 Diabetes Patients with Predominance of CD14+ Subset.
P2860
Q26749972-E39AC7D8-9635-4F36-9267-8E8507B54B70Q26798402-0E7813BA-3283-456A-A44B-BD4DE86AF2BDQ36224048-9C19BC39-7D5F-4C1C-92E9-0E545203E465Q36893225-59D5C270-25C3-439B-8D7D-F41022A1B5DFQ37596796-F0982DFE-A9D2-4A85-A9A9-83F97C29775DQ37727645-430CD59F-45EF-4042-944A-A844C7747B61Q38621047-D459F0A9-C97C-4117-B5E4-0F10BCE3C0F7Q38712457-1726358C-6AEE-4B71-A60C-DD37ECCBB14BQ38864758-32928D38-779C-4CBF-AB7E-47FE0857B07EQ38868808-EFE40784-29AC-4106-9482-370075FB9556Q39896275-B0FC918B-1549-46A0-ADAB-06458C198FA6Q40032613-FB4B74EF-8F6A-497B-818C-E82AB8672342Q47915209-2CE668CA-AD2E-461A-9F3E-2573C96C1DC8Q48769325-E1FB129B-66D2-4C2F-96D9-A05BBE1EEE53Q50020665-8F5DA741-3232-446F-954C-D0A398235B0EQ52776751-E053E515-BA9F-4EAF-B4CE-16B12E7FFF60Q55262776-EE9EAD19-A573-4C4A-A845-B81536AA8BF6
P2860
Increase in both CD14-positive and CD15-positive myeloid-derived suppressor cell subpopulations in the blood of patients with glioma but predominance of CD15-positive myeloid-derived suppressor cells in glioma tissue.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Increase in both CD14-positive ...... ressor cells in glioma tissue.
@en
type
label
Increase in both CD14-positive ...... ressor cells in glioma tissue.
@en
prefLabel
Increase in both CD14-positive ...... ressor cells in glioma tissue.
@en
P2093
P2860
P1476
Increase in both CD14-positive ...... ressor cells in glioma tissue.
@en
P2093
Barbara M Schulte
Esther D Kers-Rebel
Gosse J Adema
Harriëtte M J M Petersen-Baltussen
Kiek Verrijp
Paul R Gielen
P2860
P304
P356
10.1097/NEN.0000000000000183
P577
2015-05-01T00:00:00Z